Cocrystal Pharma (COCP) Earnings Date & Reports

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses... Show more

Industry: #Pharmaceuticals Generic

Get AI intraday signals

A.I. Advisor

published Earnings

COCP is expected to report earnings to fall 2.94% to -16 cents per share on August 17

Cocrystal Pharma COCP Stock Earnings Reports

Q2'26

Est.

$-0.17

Q1'26

Beat

by $0.09

Q4'25

Beat

by $0.12

Q3'25

Beat

by $0.15

Q2'25

Beat

by $0.17

The last earnings report on May 15 showed earnings per share of -17 cents, beating the estimate of -25 cents. With 74.32K shares outstanding, the current market capitalization sits at 13.72M.

View a ticker or compare two or three

Compare

COCP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for COCP